Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -43.16 | 45.17 |
| PEG Ratio (TTM) | 0.23 | 8.76 |
| P/S Ratio (TTM) | 2.00 | 16.04 |
| P/B Ratio (TTM) | 5.12 | 16.35 |
| P/FCF Ratio (TTM) | 16.67 | 48.82 |
| Price to 5YR AVG Earnings Ratio | -10.08 | 20.50 |
| Price to 5YR AVG FCF Ratio | -94.36 | 56.70 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.51% | 12.50% |
| ROE (TTM) | -12.14% | 57.39% |
| Net Profit Margin (TTM) | -4.64% | 23.81% |
| ROIC 5YR AVG | -103.17% | -10.92% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -20.69% | -2.77% | 23.02% |
| Revenue | 3.33% | 19.90% | 12.64% |
| Net Income | -21.89% | -12.94% | 17.30% |
| Cash Flow | 610.00% | 377.15% | 254.34% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.86 | 1.55 |
| Quick Ratio (TTM) | 0.86 | 1.53 |
| D/E Ratio (TTM) | 0.62 | 0.90 |
| Interest Coverage (TTM) | -25.53 | 55.28 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 0.06 | 11.61 |
| LTL to 5YR AVG FCF | -10.40 | 4.80 |
| Shares Outstanding Growth 5YR AVG | 4.90% | 1.80% |